Carolyn Smallwood, DO
Family Medicine · Marietta, GANPI 1093079204
Payments from drug & device makers
Across 217 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$723
- AbbVie$469
- Pfizer$398
- Lilly USA, LLC$279
- Dexcom, Inc.$258
- GSK$165
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,68699%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 48 | $723 |
| AbbVie(2 entities) | 27 | $469 |
| Pfizer | 21 | $398 |
| Lilly USA, LLC | 19 | $279 |
| Dexcom, Inc. | 10 | $258 |
| GSK | 9 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $148 |
| Johnson & Johnson | 8 | $118 |
| AstraZeneca | 8 | $115 |
| Abbott | 5 | $98 |
| Astellas Pharma US Inc | 4 | $92 |
| Exact Sciences | 5 | $80 |
| Sanofi-aventis U.S. LLC | 4 | $71 |
| Amgen | 4 | $71 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Merck | 4 | $59 |
| Novartis | 3 | $58 |
| Dynavax Technologies Corporation | 2 | $50 |
| Medtronic | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $34 |
| Boston Scientific | 1 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $27 |
| Shire North American Group Inc | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Lifescan, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Gilead | 1 | $15 |
| Biogen | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$3,709 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $56,284 |
| JardianceEmpagliflozin | 31 | $39,884 |
| TrulicityDulaglutide | 22 | $38,056 |
| JanuviaSitagliptin Phosphate | 27 | $22,383 |
| Repatha SureclickEvolocumab | 15 | $17,160 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $16,372 |
| MounjaroTirzepatide | 13 | $15,297 |
| VascepaIcosapent Ethyl | 19 | $12,689 |
| FarxigaDapagliflozin Propanediol | 12 | $12,416 |
| Repatha SyringeEvolocumab | 13 | $9,658 |
| BelsomraSuvorexant | 11 | $4,633 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $4,355 |
| Colesevelam Hcl | 13 | $4,061 |
| SynthroidLevothyroxine Sodium | 27 | $1,871 |
| Levothyroxine Sodium | 200 | $1,564 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $723 | $56,28439 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $279 | $53,35335 claims |
| Boehringer IngelheimJardiance | $27 | $39,88431 claims |
| MerckJanuvia, Belsomra | $59 | $27,01738 claims |
| AstraZenecaFarxiga | $115 | $12,41612 claims |
| AbbVieSynthroid | $469 | $1,87127 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $11 | $43613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Marietta
- Cedrice DavisMarietta$621K
- Irshad SyedMarietta$118K
- Mitzi RubinMarietta$103K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.